MOLECULAR-IDENTIFICATION OF 2 DISTINCT HEMAGGLUTININ TYPES OF MEASLES-VIRUS BY POLYMERASE CHAIN-REACTION AND RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISM (PCR-RFLP)
H. Saito et al., MOLECULAR-IDENTIFICATION OF 2 DISTINCT HEMAGGLUTININ TYPES OF MEASLES-VIRUS BY POLYMERASE CHAIN-REACTION AND RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISM (PCR-RFLP), Molecular and cellular probes, 9(1), 1995, pp. 1-8
Contemporary isolates of measles virus, characterized by their inabili
ty to hemagglutinate, have been shown to possess a hemagglutinin type
distinct from that of classical strains such as the Edmonston strain i
n that there is a new glycosylation site at amino acid residue 416. Th
is change abolishes a Sau3Al site that is found in the corresponding p
osition of the hemagglutination-positive classical strains. This molec
ular information prompted us to develop a restriction fragment length
polymorphism (RFLP) assay that is capable of distinguishing these two
distinct hemagglutinin types. The assay consists of the amplification
of a 349-bp segment of the hemagglutinin gene by reverse transcription
followed by the polymerase chain reaction and Sau3Al digestion of thi
s amplification product. The resulting two distinct RFLP patterns iden
tified the hemagglutinin types with regard to the presence or absence
of the potential new glycosylation site. This assay was applied to det
ermine the relative frequencies over a 28-year period of these two hem
agglutinin types present in the archival acute serum specimens taken f
rom patients with measles. This study revealed that strains carrying t
he classical hemagglutinin type predominated until the early 1980s whe
n it became completely replaced with strains possessing the contempora
ry hemagglutinin type. Because of its direct applicability to the clin
ical specimens avoiding selection bias during cell-culture adaptation,
this assay provides a valuable asset in both clinical laboratory and
epidemiological settings.